Wide Ranks

EXAS

Exact Sciences Corporation

61.69

Top Statistics
Market Cap 11 B Forward PE -787.77 Revenue Growth 12.80 %
Current Ratio 2.12 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -7.95 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1162.33 Enterprise / Revenue 4.89 Price To Sales Trailing12 Months 4.24
Profitability
Profit Margins -7.95 % Operating Margins -2.61 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 5.52 Total Debt 2 B
Total Debt To Equity 86.62 Current Ratio 2.12 Book Value Per Share 17.35
All Measures
Short Ratio 459.00 % Message Board Id finmb_28311 Shares Short Prior Month 15 M
Return On Equity -0.0676 City Madison Uuid cc64cb89-936d-3419-82bf-b1c20cc85a89
Previous Close 60.10 First Trade Date Epoch Utc 981 M Book Value 17.35
Beta 1.27 Total Debt 2 B Volume 2 M
Price To Book 3.56 Fifty Two Week Low 40.62 Total Cash Per Share 5.52
Total Revenue 2 B Shares Short Previous Month Date 1 B Target Median Price 70.00
Audit Risk 3 Max Age 86400 Recommendation Mean 1.39
Sand P52 Week Change 0.3133 Operating Margins -2.61 % Target Mean Price 70.81
Net Income To Common -214038000 Short Percent Of Float 0.0755 Implied Shares Outstanding 185 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 2 M
Average Volume10days 2 M Total Cash 1 B Next Fiscal Year End 1 B
Revenue Per Share 14.70 Held Percent Insiders 0.0101 Ebitda Margins -0.42 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Share Holder Rights Risk 3 Regular Market Previous Close 60.10 Target Low Price 60.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 64.19 Open 60.41
Free Cashflow 97 M State WI Dividend Yield 0.00 %
Return On Assets -0.0216 Time Zone Short Name EST Board Risk 4
Trailing Eps -1.16 Day Low 59.87 Address1 5505 Endeavor Lane
Shares Outstanding 185 M Compensation Risk 3 Price Hint 2
Target High Price 86.00 Website https://www.exactsciences.com 52 Week Change -0.0361
Average Volume 2 M Forward Eps -0.3400 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 178.30 % Is_sp_500 False
Regular Market Day High 61.94 Profit Margins -7.95 % Debt To Equity 86.62
Fifty Two Week High 79.62 Day High 61.94 Shares Short 13 M
Regular Market Open 60.41 Industry Key diagnostics-research Earnings Growth 0.00 %
Enterprise To Revenue 4.89 Revenue Growth 12.80 % Shares Percent Shares Out 0.0748
Operating Cashflow 233 M Currency USD Time Zone Full Name America/New_York
Market Cap 11 B Is_nasdaq_100 False Zip 53719
Quote Type EQUITY Industry Diagnostics & Research Long Name Exact Sciences Corporation
Overall Risk 3 Regular Market Day Low 59.87 Held Percent Institutions 1.01
Current Price 61.69 Enterprise To Ebitda -1162.33 Financial Currency USD
Current Ratio 2.12 Gross Margins 72.96 % Industry Disp Diagnostics & Research
Number Of Analyst Opinions 21 Country United States Float Shares 183 M
Two Hundred Day Average 58.10 Governance Epoch Date 1 B Ir Website http://investor.exactsciences.com
Price To Sales Trailing12 Months 4.24 Enterprise Value 13 B Forward PE -787.77
Regular Market Volume 2 M Ebitda -11337000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.

The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.

It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services.

The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests.

It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University.

Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.